Historical award
Kaleo, Inc.
This record is historical buying context, not open work.
How current is this award history?
Fiscal year 2025: data through (14 days old).
Fiscal year 2026: data through (14 days old).
Official release availability details
Fiscal year 2025: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
Fiscal year 2026: This is the latest release listed by USAspending. A latest release can still omit recent activity.
Availability checked: .
- Current award value
- $96,058,494.00
- Potential award value
- $340,910,795.00
- Total obligated to date
- $96,058,494.00
Source date: Nov 9, 2026
Recorded work
THIS ACQUISITION WILL ALLOW BARDA TO INVEST PROJECT BIOSHIELD FUNDS FOR LATE-STAGE CLINICAL DEVELOPMENT, REGULATORY APPROVAL FOR 2-PAM AUTOINJECTORS (AS A DRUG/DEVICE COMBINATION PRODUCT) TO TREAT ORGANOPHOSPHATE (OP) POISONING, INCLUDING NERVE AGENT
Award activity
- Obligations in covered fiscal years
- $96,058,494.00
- Transactions in covered fiscal years
- 1
Award value and obligated funds describe different amounts. Review the official record for the full transaction history.
Record identifier
CONT_AWD_75A50126C00010_7505_-NONE-_-NONE-